These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 37298687)

  • 1. A Targeted Mass Spectrometry Approach to Identify Peripheral Changes in Metabolic Pathways of Patients with Alzheimer's Disease.
    Reveglia P; Paolillo C; Angiolillo A; Ferretti G; Angelico R; Sirabella R; Corso G; Matrone C; Di Costanzo A
    Int J Mol Sci; 2023 Jun; 24(11):. PubMed ID: 37298687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dysregulation of multiple metabolic networks related to brain transmethylation and polyamine pathways in Alzheimer disease: A targeted metabolomic and transcriptomic study.
    Mahajan UV; Varma VR; Griswold ME; Blackshear CT; An Y; Oommen AM; Varma S; Troncoso JC; Pletnikova O; O'Brien R; Hohman TJ; Legido-Quigley C; Thambisetty M
    PLoS Med; 2020 Jan; 17(1):e1003012. PubMed ID: 31978055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unbiased Metabolomic Investigation of Alzheimer's Disease Brain Points to Dysregulation of Mitochondrial Aspartate Metabolism.
    Paglia G; Stocchero M; Cacciatore S; Lai S; Angel P; Alam MT; Keller M; Ralser M; Astarita G
    J Proteome Res; 2016 Feb; 15(2):608-18. PubMed ID: 26717242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolite profiling for the identification of altered metabolic pathways in Alzheimer's disease.
    González-Domínguez R; García-Barrera T; Gómez-Ariza JL
    J Pharm Biomed Anal; 2015 Mar; 107():75-81. PubMed ID: 25575172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolomic study of lipids in serum for biomarker discovery in Alzheimer's disease using direct infusion mass spectrometry.
    González-Domínguez R; García-Barrera T; Gómez-Ariza JL
    J Pharm Biomed Anal; 2014 Sep; 98():321-6. PubMed ID: 24992214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Widely targeted metabolomics of Alzheimer's disease postmortem cerebrospinal fluid based on 9-fluorenylmethyl chloroformate derivatized ultra-high performance liquid chromatography tandem mass spectrometry.
    Muguruma Y; Tsutsui H; Noda T; Akatsu H; Inoue K
    J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Aug; 1091():53-66. PubMed ID: 29852382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of Hair Metabolome in 5xFAD Mice and Patients with Alzheimer's Disease Using Mass Spectrometry-Based Metabolomics.
    Chang CW; Hsu JY; Lo YT; Liu YH; Mee-Inta O; Lee HT; Kuo YM; Liao PC
    ACS Chem Neurosci; 2024 Feb; 15(3):527-538. PubMed ID: 38269400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain and blood metabolite signatures of pathology and progression in Alzheimer disease: A targeted metabolomics study.
    Varma VR; Oommen AM; Varma S; Casanova R; An Y; Andrews RM; O'Brien R; Pletnikova O; Troncoso JC; Toledo J; Baillie R; Arnold M; Kastenmueller G; Nho K; Doraiswamy PM; Saykin AJ; Kaddurah-Daouk R; Legido-Quigley C; Thambisetty M
    PLoS Med; 2018 Jan; 15(1):e1002482. PubMed ID: 29370177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Graded perturbations of metabolism in multiple regions of human brain in Alzheimer's disease: Snapshot of a pervasive metabolic disorder.
    Xu J; Begley P; Church SJ; Patassini S; Hollywood KA; Jüllig M; Curtis MA; Waldvogel HJ; Faull RL; Unwin RD; Cooper GJ
    Biochim Biophys Acta; 2016 Jun; 1862(6):1084-92. PubMed ID: 26957286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of metabolomics based on direct mass spectrometry analysis for the elucidation of altered metabolic pathways in serum from the APP/PS1 transgenic model of Alzheimer's disease.
    González-Domínguez R; García-Barrera T; Vitorica J; Gómez-Ariza JL
    J Pharm Biomed Anal; 2015 Mar; 107():378-85. PubMed ID: 25656489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic profiling of Alzheimer's disease: Untargeted metabolomics analysis of plasma samples.
    Milos T; Rojo D; Nedic Erjavec G; Konjevod M; Tudor L; Vuic B; Svob Strac D; Uzun S; Mimica N; Kozumplik O; Barbas C; Zarkovic N; Pivac N; Nikolac Perkovic M
    Prog Neuropsychopharmacol Biol Psychiatry; 2023 Dec; 127():110830. PubMed ID: 37454721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Region-specific metabolic alterations in the brain of the APP/PS1 transgenic mice of Alzheimer's disease.
    González-Domínguez R; García-Barrera T; Vitorica J; Gómez-Ariza JL
    Biochim Biophys Acta; 2014 Dec; 1842(12 Pt A):2395-402. PubMed ID: 25281826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Using direct infusion mass spectrometry for serum metabolomics in Alzheimer's disease.
    González-Domínguez R; García-Barrera T; Gómez-Ariza JL
    Anal Bioanal Chem; 2014 Nov; 406(28):7137-48. PubMed ID: 25230597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain and blood metabolome for Alzheimer's dementia: findings from a targeted metabolomics analysis.
    Huo Z; Yu L; Yang J; Zhu Y; Bennett DA; Zhao J
    Neurobiol Aging; 2020 Feb; 86():123-133. PubMed ID: 31785839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Community-Based Study Identifying Metabolic Biomarkers of Mild Cognitive Impairment and Alzheimer's Disease Using Artificial Intelligence and Machine Learning.
    Yilmaz A; Ustun I; Ugur Z; Akyol S; Hu WT; Fiandaca MS; Mapstone M; Federoff H; Maddens M; Graham SF
    J Alzheimers Dis; 2020; 78(4):1381-1392. PubMed ID: 33164929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-Throughput Metabolomics for Discovering Potential Metabolite Biomarkers and Metabolic Mechanism from the APPswe/PS1dE9 Transgenic Model of Alzheimer's Disease.
    Yu J; Kong L; Zhang A; Han Y; Liu Z; Sun H; Liu L; Wang X
    J Proteome Res; 2017 Sep; 16(9):3219-3228. PubMed ID: 28753016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic Alterations in the Outer Membrane Vesicles of Patients with Alzheimer's Disease: An LC-MS/MS-based Metabolomics Analysis.
    Wei SC; Wei W; Peng WJ; Liu Z; Cai ZY; Zhao B
    Curr Alzheimer Res; 2019; 16(13):1183-1195. PubMed ID: 31755388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disturbed microbial ecology in Alzheimer's disease: evidence from the gut microbiota and fecal metabolome.
    Xi J; Ding D; Zhu H; Wang R; Su F; Wu W; Xiao Z; Liang X; Zhao Q; Hong Z; Fu H; Xiao Q
    BMC Microbiol; 2021 Aug; 21(1):226. PubMed ID: 34384375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum Metabolomic and Lipidomic Profiling Reveals Novel Biomarkers of Efficacy for Benfotiamine in Alzheimer's Disease.
    Bhawal R; Fu Q; Anderson ET; Gibson GE; Zhang S
    Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34947984
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.